Related Experiment Video

Updated: Mar 24, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K

Immune Evasion Strategies of Glioblastoma

Seyed-Mostafa Razavi1, Karen E Lee1, Benjamin E Jin1

  • 1Department of Neurosurgery, Stanford University School of Medicine , Stanford, CA , USA.

Frontiers in Surgery
|March 15, 2016
PubMed

Insights

Glioblastoma evades immune attack through its unique microenvironment. Understanding these evasion tactics is key to developing new brain tumor immunotherapies.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Biology

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with poor patient prognosis.
  • Current treatments like surgery and chemoradiation offer limited survival benefits.
  • The brain's immune-privileged status and GBM's immunosuppressive microenvironment hinder immunotherapy efficacy.

Purpose of the Study:

  • To review the mechanisms by which Glioblastoma cells evade the host immune system.
  • To highlight the challenges in applying immunotherapy to central nervous system malignancies.
  • To inform the development of novel immunotherapeutic strategies for GBM.

Main Methods:

  • Literature review of scientific articles on Glioblastoma immunology and immune evasion.
  • Analysis of established and emerging mechanisms of immune suppression by GBM.
  • Synthesis of information on the brain's immune environment and its impact on anti-tumor immunity.

Main Results:

  • GBM cells actively create an immunosuppressive tumor microenvironment.
  • Multiple strategies are employed by GBM to escape immune surveillance.
  • The brain's inherent immune privilege presents a significant barrier to effective immunotherapy.

Conclusions:

  • Elucidating GBM's immune evasion strategies is crucial for advancing treatment.
  • Targeting these evasion mechanisms may enhance the effectiveness of immunotherapies for brain tumors.
  • Further research into GBM biology and tumor immunology is needed to develop successful treatments.
Keywords:
cancer immunotherapyglioblastomaimmune evasionimmune systemimmunosuppression

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.2K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.2K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K